BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32557566)

  • 1. Holding on to the Matutes score while dropping FMC7: new opportunity from standardised approaches in multiparameter flow cytometry.
    Zhu J; Raimbault A; Sourdeau E; Maillon A; Mathis S; Capron C; Lemaire P; Ronez E; Moatti H; Jondeau K; Clauser S; Bardet V
    Br J Haematol; 2020 Aug; 190(4):e255-e258. PubMed ID: 32557566
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of CD200 to the diagnostic accuracy of Matutes score in the diagnosis of chronic lymphocytic leukemia in limited resources laboratories.
    Jalal SD
    PLoS One; 2021; 16(2):e0247491. PubMed ID: 33606850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FMC7 antigen expression on normal and malignant B-cells can be predicted by expression of CD20.
    Hübl W; Iturraspe J; Braylan RC
    Cytometry; 1998 Apr; 34(2):71-4. PubMed ID: 9579603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of expression of CD19 and CD20 in chronic B cell leukaemias.
    Ginaldi L; De Martinis M; Matutes E; Farahat N; Morilla R; Catovsky D
    J Clin Pathol; 1998 May; 51(5):364-9. PubMed ID: 9708202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic performance of the ClearLLab 10C B cell tube.
    Espasa A; Torrents S; Morales-Indiano C; Rico LG; Bardina J; Ancochea A; Bistué-Rovira À; Linio R; Raya M; Vergara S; Juncà J; Grifols JR; Petriz J; Soria MG; Sorigue M
    Cytometry B Clin Cytom; 2021 Jul; 100(4):519-530. PubMed ID: 32961011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL).
    Monaghan SA; Peterson LC; James C; Marszalek L; Khoong A; Bachta DJ; Karpus WJ; Goolsby CL
    Cytometry B Clin Cytom; 2003 Nov; 56(1):30-42. PubMed ID: 14582135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of CLL revisited: increased specificity by a modified five-marker scoring system including CD200.
    Köhnke T; Wittmann VK; Bücklein VL; Lichtenegger F; Pasalic Z; Hiddemann W; Spiekermann K; Subklewe M
    Br J Haematol; 2017 Nov; 179(3):480-487. PubMed ID: 28832948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic significance of CD20 and FMC7 expression in B-cell disorders.
    Delgado J; Matutes E; Morilla AM; Morilla RM; Owusu-Ankomah KA; Rafiq-Mohammed F; del Giudice I; Catovsky D
    Am J Clin Pathol; 2003 Nov; 120(5):754-9. PubMed ID: 14608903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunophenotyping of B chronic lymphoproliferative syndromes (CLL excluded): confrontation with the histology].
    El Borgi W; Ben Salah N; Ben Lakhal F; Makni L; Gouider E; Hafsia R
    Ann Biol Clin (Paris); 2013; 71(6):693-7. PubMed ID: 24342790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual cancer lymphocytes in patients with chronic lymphocytic leukemia after therapy show increased expression of surface antigen CD52 detected using quantitative fluorescence cytometry.
    Pevna M; Doubek M; Coupek P; Stehlikova O; Klabusay M
    Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):411-8. PubMed ID: 25066039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of CD5 in B-cell chronic lymphoproliferative diseases by flow cytometry: a strong expression in B-cell chronic lymphocytic leukemia.
    Cavalcanti Júnior GB; Sales VS; Cavalcanti e Silva DG; Lopes MC; Paiva Ade S; da Fonseca HE; do Nascimento Júniors FF; Fernandes MZ
    Acta Cir Bras; 2005; 20 Suppl 1():101-7. PubMed ID: 16186976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A classification tree approach for improving the utilization of flow cytometry testing of blood specimens for B-cell non-Hodgkin lymphoproliferative disorders.
    Healey R; Naugler C; de Koning L; Patel JL
    Leuk Lymphoma; 2015; 56(9):2619-24. PubMed ID: 25651431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating levels of soluble CD23 reflect clinical and biological features of leukemic B-cell chronic lymphoproliferative disorders.
    Vinante F; Vassanelli A; Zanotti R; Nadali G; Krampera M; Vincenzi C; Morosato L; Chilosi M; Pizzolo G
    Int J Clin Lab Res; 1995; 25(4):189-94. PubMed ID: 8788546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of cyclin D1 in B cell lymphoproliferative disorders by flow cytometry.
    Jain P; Giustolisi GM; Atkinson S; Elnenaei MO; Morilla R; Owusu-Ankomah K; Rafiq-Mohammed F; Matutes E; Wotherspoon A; Catovsky D
    J Clin Pathol; 2002 Dec; 55(12):940-5. PubMed ID: 12461064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive predictive value of CD200 positivity in the differential diagnosis of chronic lymphocytic leukemia.
    Sorigue M; Magnano L; Miljkovic MD; Nieto-Moragas J; Santos-Gomez M; Villamor N; Junca J; Morales-Indiano C
    Cytometry B Clin Cytom; 2020 Sep; 98(5):441-448. PubMed ID: 31692239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unsupervised immunophenotypic profiling of chronic lymphocytic leukemia.
    Habib LK; Finn WG
    Cytometry B Clin Cytom; 2006 May; 70(3):124-35. PubMed ID: 16498670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric evaluation of posttransplant B-cell lymphoproliferative disorders.
    Kaleem Z; Hassan A; Pathan MH; White G
    Arch Pathol Lab Med; 2004 Feb; 128(2):181-6. PubMed ID: 14736286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD200 is a useful marker in the diagnosis of chronic lymphocytic leukemia.
    Mora A; Bosch R; Cuellar C; Vicente EP; Blanco L; Martino R; Ubeda JM; Sierra J; Moreno C; Nomdedeu J
    Cytometry B Clin Cytom; 2019 Mar; 96(2):143-148. PubMed ID: 30328261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.